JavaScript is disabled.
Some features may not work properly. For the best experience, please enable JavaScript in your browser.
Ledgeburg
Sign In
Loading...
News
Latest
Latest News
Stocks
Discover
Search Stocks
ETFs
Discover
Search ETFs
Funds
Discover
Search Funds
RGNX Financials - Regenxbio Income & Cash Flow | Ledgeburg
RGNX - Regenxbio Inc.
USD | NASDAQ | Healthcare
Summary
Summary RGNX Stock
Financials
Financials RGNX Stock
Loading...
Loading...
Income Statement
Income Statement RGNX Stock
Balance Sheet
Balance Sheet RGNX Stock
Cash Flow Statement
Cash Flow Statement RGNX Stock
Loading...
Loading...
Home
Stocks
Regenxbio Inc. (RGNX)
Financials
Financials of RGNX
Loading...
Loading...
Loading...
Loading...
Revenue
$170.441M
Operating Income
$-161.198M
Net Income
$-193.878M
Share Count (Basic)
51.573M
Operating Cash Flow
$-123.963M
Free Cash Flow
$-126.377M
Cash And Short-Term Equivalents
$230.07M
Total Debt
N/A
Annual
Quarterly
Revenue $USD
0
100M
200M
300M
400M
500M
FY2021
FY2022
FY2023
FY2024
Revenue $USD
0
20M
40M
60M
80M
Q1 FY25
Q2 FY25
Q3 FY25
Q4 FY25
Q1 FY26
Annual
Quarterly
Net Income $USD
-300M
-200M
-100M
0
100M
Annual
Quarterly
Margins
Gross
Operating
Net
-300%
-200%
-100%
0%
100%
FY2025
FY2021
FY2022
FY2023
FY2024
FY2025
Net Income $USD
-100M
-80M
-60M
-40M
-20M
0
Q1 FY25
Q2 FY25
Q3 FY25
Q4 FY25
Q1 FY26
FY2021
FY2022
FY2023
FY2024
FY2025
Margins
Gross
Operating
Net
-1500%
-1000%
-500%
0%
Q1 FY25
Q2 FY25
Q3 FY25
Q4 FY25
Q1 FY26